Literature DB >> 16566374

[Retrospective evaluation of pregnancy in women suffering from systemic lupus erythematosus (SLE)].

Agata Sadowska1, Marek Hebanowski, Barbara Trzeciak, Joanna Kliszcz, Katarzyna Nowicka-Sauer, Małgorzata Waldman.   

Abstract

OBJECTIVES: Systemic lupus erythematosus (SLE) is an autoimmune disease predominantly affecting women of childbearing age, which may negatively influence the pregnancy course and outcomes. The objective of the study was to estimate the risk of fetal loss and prematurity in lupus patients. These data seem to be an important component of family counselling in lupus patients.
DESIGN: The pregnancies' course and outcomes in lupus patients and in healthy controls were compared.
MATERIAL AND METHODS: 47 lupus patients with pregnancies occurring after the diagnosis of SLE and 108 healthy controls were included in this study. The pregnancies were analysed in terms of delivery term and outcomes (live births/ miscarriage/ neonatal deaths/ congenital defects). The structured review and case histories analysis were used to gather the data.
RESULTS: The percentage of spontaneous abortions (24.1%) and preterm deliveries (24.1%) were significantly higher in lupus patients when compared with healthy controls (9.3% and 5.3% respectively).
CONCLUSIONS: The caution in pregnancy planning in lupus patients is necessary and the role of physicians' information in patients' awareness of fetal loss and prematurity is vital.

Entities:  

Mesh:

Year:  2005        PMID: 16566374

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  2 in total

1.  Mannan-binding lectin levels related to spontaneous abortion in Brazilian patients with celiac disease.

Authors:  Lorete Maria da Silva Kotze; Elisandra Grangeiro de Carvalho; Shirley Ramos da Rosa Utiyama; Renato Mitsunori Nisihara; Iara Messias-Reason
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

2.  Daphnetin inhibits inflammation in the NZB/W F1 systemic lupus erythematosus murine model via inhibition of NF-κB activity.

Authors:  Min Li; Xiaowei Shi; Fangru Chen; Fei Hao
Journal:  Exp Ther Med       Date:  2016-12-13       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.